Methylphenidate vs. resperidone in treatment of methamphetamine dependence: A clinical trial

Saudi Pharmaceutical Journal

Volumn 22, Issue 3, 2014, Pages 191-194

  Solhi, Hassan ^a   Jamilian, Hamid Reza ^a   Kazemifar, Amir Mohammad ^b   Javaheri, Javad ^a   Rasti Barzaki, Akram ^a  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abuse; Dependence; Methamphetamine; Methylphenidate; Resperidone; Treatment

Indexed keywords

METHYLPHENIDATE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG POTENCY; DSM-IV-TR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PSYCHOLOGICAL ASPECT; SYMPTOM; TREATMENT DURATION; WITHDRAWAL SYNDROME;

EID: 84904061167     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2013.04.003     Document Type: Article

References (19)

1. Anderson A.L., Li S.H., Biswas K., McSherry F., Holmes T., Iturriaga E., Kahn R., et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Dependence 2012, 120:135-141.
2. Brensilver M., Heinzerling K.G., Swanson A.N., Shoptaw S.J. A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: Suggested guidelines for treatment discontinuation/augmentation. Drug Alcohol Dependence 2012, 125:169-172.
3. Graves S.M., Rafeyan R., Watts J., Napier T.S. Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: Evidence from the bench and the bedside. Pharmacol. Therapeutics 2012, 136:343-353.
4. Heinzerling, K.G., Gadzhyan, J., van Oudheusden, H., Rodriguez, F., McCracken, J., Shoptaw, S., in press. Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence. J. Adolescent Health, 1-4, http://dx.doi.org/10.1016/j.jadohealth.2012.10.275.
5. Kazemifar A.M., Solhi H., Badakhshan D., Eidi M. Analysis of the drug crystals discovered by police 23 Sep 2008 to 20 mar 2009 in Arak. ARPN J. Eng. Appl. Sci. 2011, 6(11):48-51.
6. Kufahl P.R., Watterson L.R., Nemirovsky N.E., Hood L.E., Villa A., Halstengard C., Zautra N., Olive M.F. Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration. Neuropharmacology 2013, 66:290-301.
7. Laqueille X., Dervaux A., El Omari F., Kanit M., Bayle F.J. Methylphenidate is effective in treating amphetamine abusers with no other psychiatric disorder. Eur. Psychiat. 2005, 20:456-457.
8. Ma, J.Z., Johnson, B.A., Yu, E., Weiss, D., McSherry, F., Saadvandi, J., Iturriaga, E., et al., in press. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis. Drug Alcohol Depend http://dx.doi.org/10.1016/j.drugalcdep.2012.10.009.
9. Mooney L.J., Nielsen S., Saxon A., Hillhouse M., Thomas C., Hasson A., Stablein D., McCormack J., Lindblad R., Ling W. Cocaine use reduction with buprenorphine: rationale, design, and methodology. Contemporary Clinical Trials 2013, 34:196-204.
10. Panenka, W.J., Procyshyn, R.M., Lecomte, T., MacEwan, G.W., Flynn, S.W., Honer, W.G., Barr, A.M. in press. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Dependence http://dx.doi.org/10.1016/j.drugalcdep.2012.11.016.
11. Penetar D.M. Sustained -release opiate blockers for treating heroin and amphetamine dependence. Am. J. Psychiat. 2012, 169(5):455-457.
12. Pérez-Mañá C., Castells X., Torrens M., Capellà D., Farre M. Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database of Systematic Reviews 2012, (3). Art. No. CD009695. 10.1002/14651858.CD009695.
13. Schifano F. Drug abuse: treatment and management. Substance Abuse Disorders: Evidence and Experience 2011, 53-74. John Wiley & Sons, London. first ed. H. Ghodse, H. Herrman, M. Maj, N. Sartorius (Eds.).
14. Shoptaw S., Huber A., Peck J., Yang X., Liu J., Dang J., et al. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Dependence 2006, 85:12-18.
15. Singleton J., Degenhardt L., Hall W., Zabransky T. Mortality among amphetamine users: a systematic review of cohort studies. Drug Alcohol Dependence 2009, 105:1-8.
16. Srisurapanont M., Jarusuraisin N., Kittirattanapaiboon P. Treatment for amphetamine dependence and abuse. Cochrane Database of Systematic Reviews 2001, (4). Art. No. CD003022. 10.1002/14651858.CD003022.
17. Tiihonen J., Kuoppasalmi K., Fohr J., Tuomola P., Kuikanmaki O., Vorma H., Sokero P., Haukka J., Meririnne E. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am. J. Psychiat. 2007, 164:160-162.
18. Vearrier D., Greenberg M.I., Miller S.N., Okaneku J.T., Haggerty D.A. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis. Mon. 2012, 58:38-89.
19. White R. Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction 2000, 95(2):229-238.